DOI: 10.12890/2018_000844

Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment

Authors

  • Zsófia Vesza Hypertension and Dyslipidemia Outpatient Clinic, Medicine 4, Santa Marta's Hospital, CHLC, Lisbon, Portugal
  • Catarina Pires Hypertension and Dyslipidemia Outpatient Clinic, Medicine 4, Santa Marta's Hospital, CHLC, Lisbon, Portugal
  • Pedro Marques da Silva Hypertension and Dyslipidemia Outpatient Clinic, Medicine 4, Santa Marta's Hospital, CHLC, Lisbon, Portugal

vzsofi23@gmail.com

Keywords

Lichenoid drug eruption, dyslipidemia, statins, nutraceuticals, red yeast rice

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are generally safe and well-tolerated drugs that are extensively used for the primary and secondary prevention of atherosclerotic cardiovascular events. Muscle and liver adverse reactions are the best recognized, while cutaneous side effects are exceedingly rare. We present the case of a 65-year-old woman with severe hypercholesterolemia, who developed generalized erythematous cutaneous lesions with pruritus, resembling lichen planus, months after starting treatment with simvastatin. The symptoms disappeared on withdrawal of simvastatin and reappeared within 3 months upon rechallenge with rosuvastatin. In addition to describing a rare adverse effect of statins, the authors also discuss the nutraceutical approach to the management of a statin-intolerant patient.

View the entire article

Downloads

Published

2018-02-28

How to Cite

1.
Vesza Z, Pires C, Marques da Silva P. Statin-related Lichenoid Dermatosis: An Uncommon Adverse Reaction to a Common Treatment. EJCRIM [Internet]. 2018 Feb. 28 [cited 2026 Nov. 3];5(5). Available from: https://www.ejcrim.com/index.php/EJCRIM/article/view/844